In order to further investigate the underlying mechanism of FGL2 in promoting ccRCC, we silenced FGL2 expression in ccRCC cell line 786-O cells by small interfering RNA (siRNA) in vitro (Fig. 6A). The gene discussed is FGL2; the disease is nonpapillary renal cell carcinoma.